Phone-A-Friend
Making the Call on Improving Meningococcal Vaccine Uptake
Clinical Resource Center
Suggested Readings
Meningococcal disease in North America: updates from the Global Meningococcal Initiative.
Asturias EJ, et al. J Infect. 2022;85(6):611-622.
Meningococcal vaccination in patients with newly diagnosed asplenia in the United States.
Ghaswalla PK, et al. Vaccine. 2021;39(2):272-281.
US physicians' knowledge, attitudes, and practices regarding meningococcal vaccination for healthy adolescents and young adults.
Herrera-Restrepo O, et al. J Adolesc Health. 2024;74(6):1131-1138.
Rationale for the development of a pentavalent meningococcal vaccine: a US-focused review.
Marshall G, et al. Infect Dis Ther. 2022;11:937-951.
The Vaccine Handbook: A Practical Guide for Clinicians (12th Edition).
Marshall GS. Professional Communications, Inc., West Islip, New York, 2024.
Effectiveness, immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: results from a phase 3, randomized, controlled clinical study
Nolan T, et al. European Society for Pediatric Infectious Diseases. Lisbon, Portugal; May 8-12, 2023; Abstract O0085.
Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomized trial.
Peterson J, et al. Lancet Infect Dis. 2023;23(12):1370-1382.
Linked Resources
Patient Resources
What Patients Need to Know: Busting Myths About Meningococcal Vacinations
Guidelines
Advisory Committee on Immunization Practices (ACIP) Recommendations: Meningococcal Vaccine
Clinician Resources
Centers for Disease Control and Prevention (CDC) Clinical Guidance for Meningococcal Disease
CDC Meningococcal Vaccine Recommendations
Related activities
Webcast Series
0.25 CME/ANCC
Invasive Meningococcal Disease Burden and Outcomes
Module 1
| Faculty: | Charles P. Vega, MD, FAAFP; Gary S. Marshall, MD |
| Release: | 10/10/2024 |
| Expiration: | 10/10/2025 |
